China Otsuka Pharmaceutical

China Otsuka Pharmaceutical Co., Ltd. is a prominent pharmaceutical manufacturer in China, established in 1981 as the first Sino-Japanese pharmaceutical joint venture. The company is a subsidiary of Otsuka Pharmaceutical and is headquartered in Tianjin, where it operates extensive manufacturing facilities. It is widely recognized for its leadership in the intravenous (IV) solution market, producing a vast range of large-volume parenterals and clinical nutrition products. Beyond IV fluids, the company markets several key therapeutic drugs in the cardiovascular, respiratory, and gastrointestinal fields, including Pletaal and Meptin. China Otsuka plays a critical role in the Chinese healthcare system by providing essential medical supplies and innovative treatments. The company maintains a strong commitment to quality, adhering to international GMP standards to ensure patient safety.